What is the appropriate treatment for a patient with a symptomatic 90% right internal carotid artery stenosis presenting with a transient ischemic attack?

Treatment of 90% Right Internal Carotid Stenosis with TIA

For a patient with symptomatic 90% right internal carotid artery stenosis presenting with TIA, carotid endarterectomy (CEA) should be performed urgently—ideally within 14 days of symptom onset, and preferably within the first 48 hours to 2 weeks if the patient is neurologically stable. 1

Immediate Management Approach

Antiplatelet Therapy

Start dual antiplatelet therapy (DAPT) immediately with aspirin and clopidogrel 75 mg for at least 21 days if the patient is not proceeding directly to revascularization 1. This reduces the risk of recurrent stroke during the waiting period. After 21 days, transition to single antiplatelet therapy (clopidogrel 75 mg or aspirin) for long-term secondary prevention 1.

Urgent Surgical Evaluation

The patient requires immediate assessment by a vascular team including a neurologist 1. With 90% stenosis (classified as severe, 70-99%), this patient has a clear indication for revascularization 2, 1, 3.

Revascularization Strategy

Primary Recommendation: Carotid Endarterectomy

CEA is the first-line treatment for this patient, provided the surgical team's documented 30-day stroke/death rate is <6% 2, 1, 3. The most recent 2024 ESC guidelines strongly recommend CEA for symptomatic 70-99% stenosis (Class I, Level A evidence) 1.

Timing is Critical

The evidence consistently shows that earlier intervention yields better outcomes:

• Optimal window: within 14 days of the TIA 2, 1, 3, 1
• Ideally within 48 hours to 2 weeks if clinically stable 2, 4
• Delaying beyond 14 days significantly increases the risk of recurrent stroke while waiting

The 2018 Canadian guidelines emphasize performing CEA "on an urgent basis" and "ideally within the first days following nondisabling stroke or TIA" 2. This urgency is echoed across all major guidelines 1, 3, 5.

Age Considerations

CEA is generally more appropriate than carotid artery stenting (CAS) for patients over age 70, as current evidence indicates stenting carries higher peri-procedural stroke and death rates in older patients 2. For patients under 70 years, CAS may be considered as an alternative (Class IIb) 1.

Alternative: Carotid Artery Stenting

CAS should be considered only in specific circumstances:

• Patient is not a surgical candidate due to technical, anatomic, or medical reasons 2, 3
• Difficult surgical access (e.g., high cervical lesion, radiation-induced stenosis, restenosis after prior CEA) 3
• Patient age <70 years with appropriate anatomy 1

If CAS is performed, the interventionist must have documented peri-procedural stroke/death rates of 4-6% 2, 3.

Comprehensive Medical Management

All patients require optimal medical therapy (OMT) regardless of whether revascularization is performed 1, 3, 1, 3:

Essential Components:

• High-intensity statin therapy targeting LDL-C <1.4 mmol/L (55 mg/dL) or >50% reduction 1
• Blood pressure control (avoid perioperative hypertension which increases stroke risk) 1
• Diabetes management if present
• Smoking cessation with pharmacologic support if needed 6
• Lifestyle modifications: Mediterranean-style diet, regular physical activity 6

Post-Procedure Management

After CEA:

• Low-dose aspirin for long-term secondary prevention 1
• Duplex ultrasound surveillance within the first month, then yearly 1
• Yearly follow-up to assess cardiovascular risk factors and treatment compliance 1

After CAS (if performed):

• DAPT with aspirin and clopidogrel for at least 1 month 1
• Then transition to single antiplatelet therapy 1

Critical Pitfalls to Avoid

1. Do not delay intervention beyond 14 days—the risk of recurrent stroke increases significantly 2, 1, 3

2. Do not proceed with intervention if the surgical team's stroke/death rate exceeds 6%—the benefit is negated by excessive procedural risk 2, 1, 3

3. Do not use CAS routinely in patients >70 years—CEA has superior outcomes in this age group 2

4. Do not withhold medical therapy—OMT is mandatory even with revascularization 1, 3

5. Avoid operating within the first 48 hours if there is concern for hemorrhagic transformation or if the patient has a large infarct, impaired consciousness, or acute carotid occlusion 1

Quality Assurance

The surgeon/center must routinely audit their performance results, particularly perioperative stroke and death rates 2. The randomized trials supporting these recommendations involved combined perioperative stroke/death rates of 6-7% for CEA 2.